PRGO
37
-2
APD
55
-4
PFE
21
-4
NKE
42
3
NTRS
37
15
TSN
30
3
LMT
37
-2
HIG
71
4
HAL
29
3
GRMN
58
2
NOV
45
12
AON
50
3
VLO
35
2
SWK
56
3
QRVO
58
2
NVDA
66
-2
MET
54
4
EIX
51
-3
IPG
42
6
AES
51
-4
PRGO
37
-2
APD
55
-4
PFE
21
-4
NKE
42
3
NTRS
37
15
TSN
30
3
LMT
37
-2
HIG
71
4
HAL
29
3
GRMN
58
2
NOV
45
12
AON
50
3
VLO
35
2
SWK
56
3
QRVO
58
2
NVDA
66
-2
MET
54
4
EIX
51
-3
IPG
42
6
AES
51
-4
Financhill
Back

Range Oncology Therapeutics ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
38

CNCR
Range Oncology Therapeutics ETF

Last Price:
13.94
Seasonality Move:
2.37%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
38.86
Seasonality Move:
3.65%
Sell
38
Range Oncology Therapeutics ETF (CNCR) is a Sell

Is Range Oncology Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Oncology Therapeutics ETF [CNCR] share price is $13.88. The Score for CNCR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CNCR Stock Price Chart

What is Range Oncology Therapeutics ETF's stock price today?

  • The Range Oncology Therapeutics ETF share price today is $13.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 36.81 Sell
Chaikin Money Flow: -6575 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.36 - 15.04) Sell
Bollinger Bands (100): (14.47 - 16.39) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.49 Sell
20-day SMA: 14.59 Sell
50-day SMA: 14.87 Sell
200-day SMA: 13.46 Buy
8-day EMA: 14.41 Sell
20-day EMA: 14.6 Sell
50-day EMA: 14.88 Sell
200-day EMA: 14.25 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

Range Oncology Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

Range Oncology Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):